ADMA · Company research
ADMA Biologics, Inc. (ADMA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 10.18 | $2,206,554,717.5 | 2070534717.50 | 10.004203446826397 | — | 0.7002942412778481 | 17.7382910687728606 | 5.4054666187335868 | 80.87654281054136275017 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.